Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Not yet recruiting 3Recruiting 2Suspended 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other solid neoplasm 2

Conditions

Neoplasms 165Breast Neoplasms 163Carcinoma, Non-Small-Cell Lung 143Colorectal Neoplasms 101Prostatic Neoplasms 99Lung Neoplasms 86Ovarian Neoplasms 78Neoplasm Metastasis 72Multiple Myeloma 71Pancreatic Neoplasms 67Leukemia, Myeloid, Acute 59Endometrial Neoplasms 47Squamous Cell Carcinoma of Head and Neck 44Lymphoma 42Stomach Neoplasms 41Recurrence 40Melanoma 39Glioblastoma 39Carcinoma, Renal Cell 39Brain Neoplasms 39Carcinoma, Hepatocellular 38Urinary Bladder Neoplasms 37Precursor Cell Lymphoblastic Leukemia-Lymphoma 37Lymphoma, Non-Hodgkin 34Leukemia, Lymphocytic, Chronic, B-Cell 34Hematologic Neoplasms 34Glioma 34Sarcoma 33Esophageal Neoplasms 31Small Cell Lung Carcinoma 30

Interventions

Specimen Handling 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Solid Tumor × 30 days × Clear all
NCT06894745 2026-06-05

PET [89Zr]DFO-starPEG in Solid Tumors

University of California, San Francisco

Phase 1 Recruiting
13 enrolled
Other solid neoplasm

Solid Tumor

NCT06619587 2026-06-01

A Study to Evaluate Safety, Pharmacokinetics, and Activity of GDC-7035 as a Single Agent and in Combination in Patients With Advanced Solid Tumors

Genentech, Inc.

Phase 1 Recruiting
410 enrolled
Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡